Cardiac Magnetic Resonance in the Evaluation of COVID-19

Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Daniel E, Aggarwal, Sachin K, Phillips, Neil J, Soslow, Jonathan H, Dendy, Jeffrey M, Hughes, Sean G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Patient Care During the Pandemic and Beyond
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978025/
https://www.ncbi.nlm.nih.gov/pubmed/35399549
http://dx.doi.org/10.15420/cfr.2021.20
Descripción
Sumario:Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populations after COVID-19, such as competitive athletes with a heightened risk of sudden cardiac death, patients with multisystem inflammatory syndrome, and people suspected of having COVID-19 vaccine-induced myocarditis. This review summarises the key attributes of CMR, reviews the literature that has emerged for using CMR for people who may have COVID-19-related complications after COVID-19, and offers expert opinion regarding future avenues of investigation and the importance of reporting findings.

Ejemplares similares